4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001179110-19-009744
CEO sold 5,193 shares at $25.83 ($134,135)
- CEO acquired 8,283 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Collins Cynthia · CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-08-19 | Grant or award : show line 1 in the form | +8,283 | 16,566 | D | ||
| 2019-08-19 | Sale : show line 2 in the form | −5,193 | $25.83 | $134,135 | 11,373 | D |
| Open-market sales · 5,193 sh · avg $25.83 · $134,135 | ||||||
Loading xslF345X03/edgar.xml…